Research programme: cancer vaccines - Vaxon BiotechAlternative Names: Vbx-016; Vbx-024; Vbx-025; Vbx-026; Vbx-027; Vbx-036
Latest Information Update: 22 Apr 2016
At a glance
- Originator Vaxon Biotech
- Mechanism of Action Immunostimulants; T lymphocyte stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 09 Oct 2015 Preclinical development is ongoing for Solid tumours
- 04 May 2007 Preclinical development is ongoing for Solid tumours
- 15 Jun 2004 Preclinical trials in Solid tumours in France (IM)